Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims
Jan 09, 2019 07:00 am | Vijaya Iyer
The Centers for Medicare and Medicaid Services (CMS) has issued a permanent billing code (B4105) to Alcresta Therapeutics’ in-line digestive enzyme cartridge Relizorb, making it easier for insurance payers and potentially more accessible to patients. The code, effective on Jan. 1, should now enable coverage for Relizorb that can be separately reimbursed without any technical […]
The post Alcresta’s Relizorb Given Medicare/Medicaid Billing Code for Easier Claims appeared first on Cystic Fibrosis News Today. |
|
My Trip to Hawaii Symbolizes My Victory Over Death by CF
Jan 08, 2019 09:00 am | Brad Dell
A friend sat with me above heaven, a sapphire ocean embracing two lush islands and the greater island beneath our butts — Oahu. On that mountaintop, I rambled about finding meaning in all things. Most transplant patients I’ve met are spiritual in some way, injecting meaning where it doesn’t exist for others. We cultivate gratitude […]
The post My Trip to Hawaii Symbolizes My Victory Over Death by CF appeared first on Cystic Fibrosis News Today. |
|
Vertex and Arbor Biotechnologies Collaborating to Develop Cystic Fibrosis Gene Therapies
Jan 08, 2019 07:00 am | Catarina Silva
Vertex Pharmaceuticals and Arbor Biotechnologies have established a partnership to discover new proteins to advance the development of gene therapies for cystic fibrosis. The companies also plan to develop new genome-editing approaches for four other diseases but haven’t revealed which ones yet. Under the terms of the agreement, Arbor will primarily carry out the laboratory […]
The post Vertex and Arbor Biotechnologies Collaborating to Develop Cystic Fibrosis Gene Therapies appeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario